Sohaib is a Principal focusing on a range of life science investments.
Prior to joining CIC in 2014 he worked at Perella Weinberg Partners (London) within the Healthcare M&A team. Before this, Sohaib practised Medicine at Addenbrooke’s Hospital. He qualified in Medicine from the University of Birmingham where he also completed a PhD in CNS regeneration. In addition Sohaib holds an MPhil in Bioscience Enterprise from the University of Cambridge.
Sohaib manages CIC's investments in Abcodia, Exvastat, PolyProx and Z Factor.